Why Amarin Stock Tumbled in November

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 7 December, 2021 by The TZ Newswire Staff

Why Amarin Stock Tumbled in November

Shares of the cardiovascular disease specialist Amarin (NASDAQ: AMRN) lost approximately a quarter of their value during the month of November, according to data from S&P Global Market I

See also
- Next Article Scottish oysters were on the rocks. Now a whiskey distillery is throwing them a lifeline
- Previous Article Avid Bioservices, inc (CDMO) Q2 2022 Earnings Call Transcript
Editorial Calender

December 2021

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30 31

« Nov Jan »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 7 December, 2021 by The TZ Newswire Staff

Why Amarin Stock Tumbled in November

See also

Editorial Calender

Recent Tags